Latest news
Loading news…
D2B3
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. New Haven, Connecticut, United States 1-10 employees For Profit
D2B3is a pre-clinical biotechnology startup dedicated to creating innovative drug delivery technologies for the brain.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 2
- IT spend
- $80.09K
Company Info
- Employees
- 1-10
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 3
- HQ
- New Haven, Connecticut, United States
- Region
- East Coast, New England, Northeastern US
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- -0.1
- Trend (30d)
- 1.4
- Trend (90d)
- 0.8
Key People at D2B3
Co-Founder
CEO & Co-Founder
CSA & Co-Founder
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to D2B3
Loading news…
FAQs about D2B3
People who checked this page also checked these
Browse the full Acquirezy directory.